Cleared Traditional

TEMPOARY POLYCARBONATE CROWNS (K932759) - FDA 510(k) Clearance

Class I Dental device.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1994
Decision
409d
Days
Class 1
Risk

K932759 is an FDA 510(k) clearance for the TEMPOARY POLYCARBONATE CROWNS. Classified as Crown, Preformed (product code ELZ), Class I - General Controls.

Submitted by South American Dental Exporting Corp. (Hialeah, US). The FDA issued a Cleared decision on July 22, 1994 after a review of 409 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Dental FDA review panel, regulated under 21 CFR 872.3330 - the FDA dental device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Dental submissions.

View all South American Dental Exporting Corp. devices

Submission Details

510(k) Number K932759 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 08, 1993
Decision Date July 22, 1994
Days to Decision 409 days
Submission Type Traditional
Review Panel Dental (DE)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
282d slower than avg
Panel avg: 127d · This submission: 409d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code ELZ Crown, Preformed
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 872.3330
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.